• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

982
82
61
58
47

COUNTRY

56
19
10
6
5

CATEGORIES

  • 82
  • 120
  • 66
  • 66
  • 36
  • 37
  • 11
  • 11
  • 12
  • 18

PRICE

550
813
1,789
2,612

PUBLISHED

8
244
684
2,612

PRODUCT TYPE

2,461
76
62
12
1

Oncology

The American Cancer Society forecasts that 1,638,910 new cancer cases will occur in the United States in 2012. As cancer rates worldwide are increasing, the oncological sector of the pharmaceutical industry is growing fast and it will continue to provide business opportunities in the next years. However, cancer trials are some of the most complex, time consuming and expensive across all therapeutic areas. What are the new paths to success in this lucrative but challenging market?

Find out the answer in the reports, books, and subscriptions listed under Research and Markets’ Oncology category. Our top-quality publications from industry experts cover every aspect of cancer drug therapy, with a focus on: Lung Cancer, Breast Cancer, Prostate Cancer, Leukaemia, Lymphoma, Ovarian Cancer, Colon Cancer, Cervical Cancer, Brain Cancer and Bladder Cancer. So read on for the latest clinical trials, pipeline reviews, industry news, and commercial opportunities.

Key players featured in our publications include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Wyeth, and many more. Show Less
Read more

PRODUCT TITLE
Neuroendocrine Tumors Drug Pathway Analyzer 2015 Neuroendocrine Tumors Drug Pathway Analyzer 2015 - Product Thumbnail Image

Neuroendocrine Tumors Drug Pathway Analyzer 2015

Extra value: One year of free online updates included with this product There are today at least 65 targeted molecular therapies known to affect more than 215 specific intracellular signaling pathways...

January 2015
FROM
Ovarian Cancer Drug Pathway Analyzer 2015 Ovarian Cancer Drug Pathway Analyzer 2015 - Product Thumbnail Image

Ovarian Cancer Drug Pathway Analyzer 2015

Extra value: One year of free online updates included with this product There are today at least 349 targeted molecular therapies known to affect more than 250 specific intracellular signaling pathways...

January 2015
FROM
Lung Cancer Drug Pathway Analyzer 2015 Lung Cancer Drug Pathway Analyzer 2015 - Product Thumbnail Image

Lung Cancer Drug Pathway Analyzer 2015

Extra value: One year of free online updates included with this product There are today at least 548 targeted molecular therapies known to affect more than 257 specific intracellular signaling pathways...

January 2015
FROM
Prostate Cancer Drug Pathway Analyzer 2015 Prostate Cancer Drug Pathway Analyzer 2015 - Product Thumbnail Image

Prostate Cancer Drug Pathway Analyzer 2015

Extra value: One year of free online updates included with this product There are today at least 413 targeted molecular therapies known to affect more than 249 specific intracellular signaling pathways...

January 2015
FROM
Leukemia Drug Pathway Analyzer 2015 Leukemia Drug Pathway Analyzer 2015 - Product Thumbnail Image

Leukemia Drug Pathway Analyzer 2015

Extra value: One year of free online updates included with this product There are today at least 435 targeted molecular therapies known to affect more than 246 specific intracellular signaling pathways...

January 2015
FROM
Melanoma Drug Pathway Analyzer 2015 Melanoma Drug Pathway Analyzer 2015 - Product Thumbnail Image

Melanoma Drug Pathway Analyzer 2015

Extra value: One year of free online updates included with this product There are today at least 303 targeted molecular therapies known to affect more than 251 specific intracellular signaling pathways...

January 2015
FROM
Protein Kinase Inhibitors Drug Pathway Analyzer 2015 Protein Kinase Inhibitors Drug Pathway Analyzer 2015 - Product Thumbnail Image

Protein Kinase Inhibitors Drug Pathway Analyzer 2015

Extra value: One year of free online updates included with this product There are today at least 995 protein kinase inhibitor drugs known to affect more than 250 specific intracellular signaling pathways...

January 2015
FROM
RNAs (miRNA, RNAi & siRNA) in Oncology: Drug Pathway Analyzer 2015 RNAs (miRNA, RNAi & siRNA) in Oncology: Drug Pathway Analyzer 2015 - Product Thumbnail Image

RNAs (miRNA, RNAi & siRNA) in Oncology: Drug Pathway Analyzer 2015

Extra value: One year of free online updates included with this product There are today at least 67 RNA (miRNA, RNAi & siRNA) drugs known to affect more than 159 specific intracellular signaling pathways...

January 2015
FROM
Global Head and Neck Cancer Epidemiology and Patient Flow Analysis - 2015 Global Head and Neck Cancer Epidemiology and Patient Flow Analysis - 2015 - Product Thumbnail Image

Global Head and Neck Cancer Epidemiology and Patient Flow Analysis - 2015

The author announced the results of its Head and Neck Cancer patient population study in a new report ‘Global Head and Neck Cancer Epidemiology and Patient Flow Analysis - 2015’. The report provides...

January 2015
FROM
Global Gastric Cancer Epidemiology and Patient Flow Analysis - 2015 Global Gastric Cancer Epidemiology and Patient Flow Analysis - 2015 - Product Thumbnail Image

Global Gastric Cancer Epidemiology and Patient Flow Analysis - 2015

The author announced the results of its Gastric Cancer patient population study in a new report ‘Global Gastric Cancer Epidemiology and Patient Flow Analysis - 2015’. The report provides insights into...

January 2015
FROM
Global Cervical Cancer Epidemiology and Patient Flow Analysis - 2015 Global Cervical Cancer Epidemiology and Patient Flow Analysis - 2015 - Product Thumbnail Image

Global Cervical Cancer Epidemiology and Patient Flow Analysis - 2015

The author announced the results of its Cervical Cancer patient population study in a new report ‘Global Cervical Cancer Epidemiology and Patient Flow Analysis - 2015’. The report provides insights...

January 2015
FROM
Global Bladder Cancer Epidemiology and Patient Flow Analysis - 2015 Global Bladder Cancer Epidemiology and Patient Flow Analysis - 2015 - Product Thumbnail Image

Global Bladder Cancer Epidemiology and Patient Flow Analysis - 2015

The author announced the results of its Bladder Cancer patient population study in a new report ‘Global Bladder Cancer Epidemiology and Patient Flow Analysis - 2015’. The report provides insights into...

January 2015
FROM
Global Breast Cancer Epidemiology and Patient Flow Analysis - 2015 Global Breast Cancer Epidemiology and Patient Flow Analysis - 2015 - Product Thumbnail Image

Global Breast Cancer Epidemiology and Patient Flow Analysis - 2015

The author announced the results of its Breast Cancer patient population study in a new report ‘Global Breast Cancer Epidemiology and Patient Flow Analysis - 2015’. The report provides insights into...

January 2015
FROM
Global Prostate Cancer Epidemiology and Patient Flow Analysis - 2015 Global Prostate Cancer Epidemiology and Patient Flow Analysis - 2015 - Product Thumbnail Image

Global Prostate Cancer Epidemiology and Patient Flow Analysis - 2015

The author announced the results of its Prostate Cancer patient population study in a new report ‘Global Prostate Cancer Epidemiology and Patient Flow Analysis - 2015’. The report provides insights...

January 2015
FROM
Global Ovarian Cancer Epidemiology and Patient Flow Analysis - 2015 Global Ovarian Cancer Epidemiology and Patient Flow Analysis - 2015 - Product Thumbnail Image

Global Ovarian Cancer Epidemiology and Patient Flow Analysis - 2015

The author announced the results of its Ovarian Cancer patient population study in a new report ‘Global Ovarian Cancer Epidemiology and Patient Flow Analysis - 2015’. The report provides insights into...

January 2015
FROM
2015 World Cancer Diagnostics Market Key Players: Strategic Assessments of Major Suppliers and Emerging Market Entrants 2015 World Cancer Diagnostics Market Key Players: Strategic Assessments of Major Suppliers and Emerging Market Entrants - Product Thumbnail Image

2015 World Cancer Diagnostics Market Key Players: Strategic Assessments of Major Suppliers and Emerging Market Entrants

This report presents strategic analyses of major current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological...

January 2015
FROM
2015 Global Cancer Market Overview: Facilities, Test Volumes, and Sales Forecasts by Country 2015 Global Cancer Market Overview: Facilities, Test Volumes, and Sales Forecasts by Country - Product Thumbnail Image

2015 Global Cancer Market Overview: Facilities, Test Volumes, and Sales Forecasts by Country

This report provides a worldwide overview of the cancer diagnostics market, including mortality statistics and scientific views on the etiology of major types of cancer, estimates of the number of laboratories...

January 2015
FROM
Alpha6 Beta4 Integrin Signaling Pathway in Oncology Drug Pipeline Update 2015 Alpha6 Beta4 Integrin Signaling Pathway in Oncology Drug Pipeline Update 2015 - Product Thumbnail Image

Alpha6 Beta4 Integrin Signaling Pathway in Oncology Drug Pipeline Update 2015

The Alpha6 Beta4 Integrin signaling pathway activates the PI 3-kinase/Akt, MAPK/NFkB and SMAD signaling modules. There are today 267 companies plus partners developing 353 Alpha6Beta4 integrin pathway...

January 2015
FROM
B Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2015 B Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2015 - Product Thumbnail Image

B Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2015

Activation of the B cell receptor involves phosphorylation of the cytoplasmic immunoreceptor tyrosine-based activation motifs (ITAMs) present in Ig alpha and beta. This leads to activation of several...

January 2015
FROM
Biologicals in Oncology Drug Pipeline Update 2015 Biologicals in Oncology Drug Pipeline Update 2015 - Product Thumbnail Image

Biologicals in Oncology Drug Pipeline Update 2015

This drug pipeline update covers a wide array of biological drugs, such as: antibodies,proteins, peptides, DNA, RNA and cellular therapies. There are today 980 companies plus partners developing 1676...

January 2015
FROM
Loading Indicator

Our Clients

Photocure ASA Roche Diagnostics Ltd. Abbott Laboratories Ltd. Pfizer, Inc. Novartis AG Becton, Dickinson and Company (BD)